These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19224210)

  • 1. Effects of medial temporal lobe degeneration on brain perfusion in amnestic MCI of AD type: deafferentation and functional compensation?
    Guedj E; Barbeau EJ; Didic M; Felician O; de Laforte C; Ranjeva JP; Poncet M; Cozzone PJ; Mundler O; Ceccaldi M
    Eur J Nucl Med Mol Imaging; 2009 Jul; 36(7):1101-12. PubMed ID: 19224210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment.
    Sheng C; Xia M; Yu H; Huang Y; Lu Y; Liu F; He Y; Han Y
    PLoS One; 2017; 12(6):e0179823. PubMed ID: 28650994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer's Disease Dementia.
    Pasquini L; Scherr M; Tahmasian M; Myers NE; Ortner M; Kurz A; Förstl H; Zimmer C; Grimmer T; Akhrif A; Wohlschläger AM; Riedl V; Sorg C
    J Alzheimers Dis; 2016; 51(1):313-26. PubMed ID: 26836175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
    Jauhiainen AM; Pihlajamäki M; Tervo S; Niskanen E; Tanila H; Hänninen T; Vanninen RL; Soininen H
    Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.
    Nobili F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Calvini P; Morbelli S; De Carli F; Guerra UP; Van de Pol LA; Visser PJ
    J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of medial temporal and posteromedial cortices in early Alzheimer's disease.
    Miettinen PS; Pihlajamäki M; Jauhiainen AM; Niskanen E; Hänninen T; Vanninen R; Soininen H
    Eur J Neurosci; 2011 Jul; 34(2):320-30. PubMed ID: 21692882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    Jarholm JA; Bjørnerud A; Dalaker TO; Akhavi MS; Kirsebom BE; Pålhaugen L; Nordengen K; Grøntvedt GR; Nakling A; Kalheim LF; Almdahl IS; Tecelão S; Fladby T; Selnes P
    J Alzheimers Dis; 2023; 94(1):259-279. PubMed ID: 37248900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography.
    Hirao K; Ohnishi T; Matsuda H; Nemoto K; Hirata Y; Yamashita F; Asada T; Iwamoto T
    Nucl Med Commun; 2006 Feb; 27(2):151-6. PubMed ID: 16404228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between Z-scores of VSRAD and regional cerebral blood flow of SPECT in patients with Alzheimer's disease and mild cognitive impairment.
    Li X; Shimizu S; Jibiki I; Watanabe K; Kubota T
    Psychiatry Clin Neurosci; 2010 Jun; 64(3):284-92. PubMed ID: 20374539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct medial temporal contributions to different forms of recognition in amnestic mild cognitive impairment and Alzheimer's disease.
    Westerberg C; Mayes A; Florczak SM; Chen Y; Creery J; Parrish T; Weintraub S; Mesulam MM; Reber PJ; Paller KA
    Neuropsychologia; 2013 Oct; 51(12):2450-61. PubMed ID: 23831717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    Tai H; Hirano S; Sakurai T; Nakano Y; Ishikawa A; Kojima K; Li H; Shimada H; Kashiwado K; Mukai H; Horikoshi T; Sugiyama A; Uno T; Kuwabara S
    J Alzheimers Dis; 2020; 78(4):1639-1652. PubMed ID: 33185599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional compensation in incipient Alzheimer's disease.
    Caroli A; Geroldi C; Nobili F; Barnden LR; Guerra UP; Bonetti M; Frisoni GB
    Neurobiol Aging; 2010 Mar; 31(3):387-97. PubMed ID: 18554752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study.
    Garrido GE; Furuie SS; Buchpiguel CA; Bottino CM; Almeida OP; Cid CG; Camargo CH; Castro CC; Glabus MF; Busatto GF
    J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):508-16. PubMed ID: 12397142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease.
    Karas GB; Scheltens P; Rombouts SA; Visser PJ; van Schijndel RA; Fox NC; Barkhof F
    Neuroimage; 2004 Oct; 23(2):708-16. PubMed ID: 15488420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
    Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
    Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal perfusion in mild Alzheimer's disease.
    Rodriguez G; Vitali P; Calvini P; Bordoni C; Girtler N; Taddei G; Mariani G; Nobili F
    Psychiatry Res; 2000 Dec; 100(2):65-74. PubMed ID: 11114492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M; Vinyes-Junqué G; Boada M; Martínez-Lage P; Cuberas G; Espinosa A; Roca I; Hernández I; Valero S; Rosende-Roca M; Mauleón A; Becker And JT; Tárraga L
    J Alzheimers Dis; 2010; 21(2):557-67. PubMed ID: 20555146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.
    Pennanen C; Kivipelto M; Tuomainen S; Hartikainen P; Hänninen T; Laakso MP; Hallikainen M; Vanhanen M; Nissinen A; Helkala EL; Vainio P; Vanninen R; Partanen K; Soininen H
    Neurobiol Aging; 2004 Mar; 25(3):303-10. PubMed ID: 15123335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.